Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 8, 2015
0Patent Application Number
139072020
Date Filed
May 31, 2013
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
